Mural Health and Clinflash Announce Strategic Partnership
Mural Health has announced a strategic partnership with Clinflash. The partnership will expand the capacity and global market of patient payments for clinical trials. Having reached a global agreement, the partnership intends to enable sponsors to access patient payment solutions in the Chinese market and beyond.
Mural Health's participant management platform Mural Link™, has introduced a patient payments system and Clinflash ePAY (Clinical Trial Electronic Payment Solution) uses digital service technology to improve payment efficiency and security. The company has established close cooperation with key hospitals in China to provide third-party mobile payment solutions for Chinese trial participants.
Reference
Mural Health and China-based Clinflash Partner to Expand Global Patient Payment Solutions. (2023 May, 23). Cision PR Newswire.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
STEP UP Trial Shows Semaglutide 7.2 mg Achieves Superior Weight Loss vs. 2.4 mg, Placebo
January 17th 2025Semaglutide 7.2 mg significantly outperformed semaglutide 2.4 mg and placebo with a 20.7% average reduction in weight and a comparable safety and tolerability profile, further establishing its efficacy in obesity treatment.
